Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The human type II 5α-reductase gene has a specific structure important for understanding certain medical conditions.

The document concludes that targeting 5α-reductase, the androgen receptor, and hair growth genes, along with using compounds with anti-androgenic properties, could lead to more effective hair loss treatments.

DHT, a testosterone byproduct, causes male pattern baldness.

Androgen conjugates might be better indicators of skin sensitivity to hormones in women with excessive hair growth.

Genes and hormones cause hair loss, with four genes contributing equally.

The enzyme 17β-HSD type 2 mainly performs oxidation in human sebaceous glands, which may help protect against acne.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

The conclusion is that formalizing how past decisions influence current health technology assessments could improve the credibility and defense of coverage decisions.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Certain 4-azasteroids are effective at blocking the enzyme that processes testosterone in human skin and could help treat acne, excessive hair growth, and male pattern baldness.

Women with polycystic ovary syndrome tend to have a longer anogenital distance.

Steroidogenic isoenzymes may help improve treatments for common hair loss.

Reduced sexual drive may be linked to male breast cancer, while anti-estrogenic factors might lower the risk.

Women with PCOS have higher levels of AMH in their blood and follicles, and this can help predict their risk of overreaction to fertility treatments.

Finasteride for hair loss increases risk of long-lasting sexual dysfunction.

Finasteride caused enlarged breast tissue in a 62-year-old man.

Rare adrenal cancers that secrete androgens or estrogens have a poor prognosis and are treated primarily with surgery.

Alternative treatments show promise for hair growth beyond traditional methods.

Combination therapies work better than single treatments for hair loss.

Finasteride doesn't affect oral testosterone undecanoate, and high DHT levels may cause acne, prostate issues, and hair loss.

A woman's masculine symptoms were caused by an ovarian tumor, which improved after surgery.

Finasteride use may increase the risk of male breast cancer.

Proscar (finasteride) blocks 5α-reductase in sea urchin ovaries and testes, suggesting potential treatment for androgen-related conditions.

Finasteride-loaded ethosomes improve hair loss treatment by targeting pilosebaceous unit.

Men with male pattern baldness have a higher risk of aggressive prostate cancer and benign prostatic hyperplasia.

The conclusion is that a systematic approach is key for treating symmetrical alopecia in dogs, but treatment may not always be necessary.

Men, particularly those with hair loss, are more likely to get the virus, and those with prostate cancer may have milder symptoms. Testosterone's role in the disease is unclear, and the virus doesn't seem to harm male fertility. Women with PCOS might be at higher risk. More research is needed.

The report suggests that the same underlying issue in blood vessel support may cause angiokeratomas on both the scrotum and eyelids.

The mesenchymal stem cell-conditioned medium gel improved burn healing and hair growth in rats better than other treatments.

A new method was created to test the effectiveness of Dihydrotestosterone (DHT) inhibitors, like finasteride and dutasteride, in human and fish cells. The results showed fish cells are more sensitive to these treatments, and dutasteride works better than finasteride in all tested cells.